close Icon

Research Articles

Explore our library of peer-reviewed publications below, with contributions from Burnet researchers.

See also: Research Reports + Policy Briefs

Form Loading Icon
Ex-vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.

Mountford J, Octaviana F, Estiasari R, Setiawan DD, Ariyanto I, Lee S, Gaff J, Chew C, Jackaman C, Kamerman P, Cherry C, Price P

Ex-vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
Training for Tuberculosis Elimination in Indonesia: Achievements, Reflections, and Potential for Impact.

Main S, Lestari T, Triasih R, Chan G, Davidson L, Majumdar S, Santoso D, Phung S, Laukkala J, Graham S, du Cros P, Ralph A.

Tuberculosis (TB) Training for Tuberculosis Elimination in Indonesia: Achievements, Reflections, and Potential for Impact.
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.

Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, Auburn S, Chand K, Chau NH, Cheah PY, Dong LT, Dhorda M, Degaga TS, Devine A, Ekawati LL, Fahmi F, Hailu A, Hasanzai MA, Hien TT, Khu H, Ley B, Lubell Y, Marfurt J, Mohammad H, Moore KA, Naddim MN, Pasaribu AP, Pasaribu S, Promnarate C, Rahim AG, Sirithiranont P, Solomon H, Sudoyo H, Sutanto I, Thanh NV, Tuyet-Trinh NT, Waithira N, Woyessa A, Yamin FY, Dondorp A, Simpson JA, Baird JK, White NJ, Day NP, Price RN

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.

Goss CW, O'Brian K, Dubray C, Fischer PU, Hardy M, Jambulingam P, King CL, Laman M, Lemoine JF, Robinson LJ, Samuela J, Subramanian S, Supali T, Weil GJ, Schechtman KB

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4.

Gilson PR, Kumarasingha R, Thompson J, Zhang X, Penington JS, Kalhor R, Bullen HE, Lehane AM, Dans MG, de Koning-Ward TF, Holien JK, Soares da Costa TP, Hulett MD, Buskes MJ, Crabb BS, Kirk K, Papenfuss AT, Cowman AF, Abbott BM

Malaria A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4.
"you need a cash buffer”: male sex work and condom use in the era of HIV pre-exposure prophylaxis.

Callander D, Bell Stephen, Minichiello V, Deveau R, Prestage G, Donovan B

HIV + AIDS Sexually Transmitted Infections (STI's) "you need a cash buffer”: male sex work and condom use in the era of HIV pre-exposure prophylaxis.